Perrigo Co. Plc (PRGO)

51.56
NYSE : Health Technology
Prev Close 51.41
Day Low/High 51.32 / 51.90
52 Wk Low/High 36.28 / 80.66
Avg Volume 1.19M
Exchange NYSE
Shares Outstanding 135.99M
Market Cap 6.99B
EPS 0.90
P/E Ratio 60.48
Div & Yield 0.84 (1.55%)
Google, Amazon Lift Tech Sector as Nasdaq Hovers in Record Territory

Google, Amazon Lift Tech Sector as Nasdaq Hovers in Record Territory

The Nasdaq and S&P 500 hover at record highs.

Teva Won't Let Regulators, Poison Pill Stop Its Quest for Mylan

Teva Won't Let Regulators, Poison Pill Stop Its Quest for Mylan

Teva has a path to complete the deal.

Japanese Stocks Hit 15-Year High

And four other things you need to know now.

Market Wrap: Major Indexes End Mixed

U.S. stocks were mixed on Tuesday.

Earnings and Marriage Season

Biotech companies are saying, "I do."

Akorn Rises, Perrigo Slips After Teva Makes Long-Rumored Mylan Bid

Akorn Rises, Perrigo Slips After Teva Makes Long-Rumored Mylan Bid

The shares of drugmaker Akorn are rising after Israeli pharmaceutical company Teva earlier today made a takeover bid for another company in the space, generic drugmaker Mylan.

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Mylan's deal to buy Perrigo is taking another potential target off the block.

When Should You Sell Your Kraft, Alcatel or Hospira Stock?

When Should You Sell Your Kraft, Alcatel or Hospira Stock?

On the heels of Nokia's proposed Alcatel Lucent purchase, here's a closer look at what to do with a stock after a M&A, regardless of whether you already own it.

3 Drugs Stocks Pushing The Industry Higher

3 Drugs Stocks Pushing The Industry Higher

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace

The recent bid by Mylan to acquire Perrigo offers the latest example of pharma companies that have been seeking growth opportunities.

Say It With Me: Specialty Pharma

These companies are the hottest thing going.

Infinera Picks Up Optical-Network Systems Maker Transmode With $345M Offer

Infinera Picks Up Optical-Network Systems Maker Transmode With $345M Offer

California-based optical firm Infinera plans to purchase an optical-network systems maker, Transmode, with $345M offer, joining this week's swirl of deal activity involving European companies.

Small-Cap M&A Flies Under the Radar

Small-Cap M&A Flies Under the Radar

Recent activity has heated up and is creating shareholder value.

Trade-Ideas: Perrigo (PRGO) Is Today's Unusual Social Activity Stock

Trade-Ideas: Perrigo (PRGO) Is Today's Unusual Social Activity Stock

Trade-Ideas LLC identified Perrigo (PRGO) as an unusual social activity candidate

April 9 Premarket Briefing: 10 Things You Should Know

April 9 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are flat Thursday. Earnings season is underway and investors are still considering Wednesday's big proposed mergers in energy and pharmaceuticals.

Day Ahead: Good News from Overseas

But rate jitters still persist in the U.S.

Jim Cramer -- Mylan's Move to Acquire Perrigo a Prescription for Success

Jim Cramer -- Mylan's Move to Acquire Perrigo a Prescription for Success

The drug companies' strengths in generics and knocks-off drugs should complement one another.

Jim Cramer's Top Takeaways: Southwest Airlines, Children's Place, Mylan, Royal Dutch Shell

Jim Cramer's Top Takeaways: Southwest Airlines, Children's Place, Mylan, Royal Dutch Shell

Southwest and Spirit are Cramer's favorite airlines but he says the Royal Dutch Shell deal for BG Group is an 'embarrassment.'

Greece Said to Be Able to Pay IMF

And four other things you need to know now.

Jim Cramer's 'Mad Money' Recap: Really, Cheaper Oil Is Good for Stocks

Jim Cramer's 'Mad Money' Recap: Really, Cheaper Oil Is Good for Stocks

The market got a gift today, says Cramer. So why were investors heading for the hills?

Mylan Bids $29 Billion for Perrigo in Latest Big Pharma Deal

Mylan Bids $29 Billion for Perrigo in Latest Big Pharma Deal

Mylan made public on Wednesday that it had made a proposal to acquire generic drugmaker Perrigo in a deal valued at $205 per share in cash and stock.

Market News: Mylan, Global Payments, OneBeacon Insurance Group

Market News: Mylan, Global Payments, OneBeacon Insurance Group

The stock markets in the United States fluctuated and eventually ended higher after the Federal Reserve released the minutes of its meeting indicating that policy makers are divided on raising interes...

Market Wrap: Digesting the Minutes

The Fed minutes produced little fanfare.

Stocks Eke Out Gains After Divided Fed Fuels Choppiness

Stocks Eke Out Gains After Divided Fed Fuels Choppiness

Wall Street was as divided as the Federal Reserve on Wednesday.

Mylan Deal the Rx for Drug Stocks

Even the second-tier biotechs are taking off.

Stocks Pop After March Minutes Show Fed Divided on Rate Hike Timing

Stocks Pop After March Minutes Show Fed Divided on Rate Hike Timing

Stocks pop Wednesday as the minutes of the Federal Reserve meeting in March show the central bank divided in its thinking about rate hikes.

Mylan Deal Is All That Shell Is Not

The ecstasy and the agony of M&A all in one day.

Perrigo (PRGO) Stock Is Up Today Following Mylan Proposal

Perrigo (PRGO) Stock Is Up Today Following Mylan Proposal

Perrigo (PRGO) is gaining Wednesday on Mylan's (MYL) proposal to acquire the company.

Watch Out: Barbarians At The Gate For Perrigo (PRGO)

Watch Out: Barbarians At The Gate For Perrigo (PRGO)

Trade-Ideas LLC identified Perrigo (PRGO) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Jim Cramer's 12 Best Health Care Stocks to Buy Right Now

Jim Cramer's 12 Best Health Care Stocks to Buy Right Now

Which are the best stocks to buy now if you're worried about economic sensitivity? Health care stocks.

TheStreet Quant Rating: D+ (Sell)